ORIC Pharmaceuticals Inc.

ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to improving the lives of cancer patients by addressing treatment resistance. The company's focus lies in developing innovative therapies that target the various mechanisms by which cancer cells become resistant to existing treatments. ORIC leverages its expertise in precision oncology, key tumor dependencies, and hormone-dependent cancers to create novel agents that can overcome innate, acquired, and bypass resistance mechanisms.

ORIC's pipeline features multiple promising candidates, including ORIC-114, a brain-penetrant EGFR/HER2 inhibitor, ORIC-944, a PRC2 inhibitor, and ORIC-533, a CD73 inhibitor. The company has a strong leadership team with extensive experience in oncology drug development and commercialization. They have established a collaborative culture that emphasizes excellence, inclusivity, and employee empowerment. ORIC is committed to engaging with its communities and providing comprehensive benefits to its employees.

ORIC Pharmaceuticals offers flexible schedules and hybrid work arrangements as appropriate for the role. This means that employees have some control over their work hours and location, allowing for a balance between work and personal life. However, the specific level of flexibility will vary depending on the individual's role and responsibilities.

ORIC Pharmaceuticals offers a competitive total rewards package designed to support employee health and wellness, financial security, and career growth. These benefits include equity grants, competitive base salaries, and annual bonuses, along with a 401(k) plan with a generous company match and participation in an Employee Stock Purchase Plan. Comprehensive health insurance options, including PPO, HMO, and Kaiser, are provided with significant company contributions. A wellbeing allowance, employee support program, and travel assistance program are also included. ORIC provides a generous vacation and sick time policy, as well as paid parental and bereavement leave. Employee perks and programs include flexible schedules, a peer recognition program, annual service awards, and weekly lunches and breakfasts. ORIC further invests in employee growth through guest speakers, professional development training sessions, LinkedIn Learning, and scientific career development ladders.

ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing novel therapies that overcome resistance in cancer. Their mission is to improve the lives of patients by tackling the problem of cancer treatment resistance, which limits the efficacy and duration of clinical benefit of existing treatments. They are focused on developing therapies that address three key types of resistance: innate, acquired, and bypass resistance.

ORIC Pharmaceuticals promotes a collaborative and empowering culture that prioritizes patient health and scientific excellence. They value transparency, data-driven decisions, and contributions at all levels, creating an inclusive and inquisitive environment where healthy debate is encouraged. ORIC also emphasizes a sense of shared purpose, offering a supportive and fun work environment where employees are encouraged to take on challenges and connect with the patient populations they serve.

ORIC Pharmaceuticals is committed to fostering a diverse, equitable, and inclusive workplace. The company values transparency, data-driven decisions, and contributions from all levels. They strive to create a welcoming environment where healthy debate and respectful treatment are the norm, and they recognize the importance of providing employees with comprehensive health coverage, financial security, and a work environment that contributes to their well-being.